🇺🇸 FDA
Patent

US 8957033

Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof

granted A61KA61K31/351A61K31/70

Quick answer

US patent 8957033 (Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof) held by Beijing Prelude Pharm. SCI. & Tech. Co., Ltd. expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Beijing Prelude Pharm. SCI. & Tech. Co., Ltd.
Grant date
Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/351, A61K31/70, A61K45/06, A61K9/0019